Related Experiment Video
Updated: May 2, 2026
Urokinase-type Plasminogen Activator-induced Mouse Back Pain Model
Published on: September 1, 2023
Effects of tissue plasminogen activator in experimentally induced peritonitis
Başak Erginel1, Lütfiye Oksüz2, Turgay Erginel3
1Department of Pediatric Surgery, İstanbul University İstanbul Faculty of Medicine, İstanbul, Turkey. basakerginel@hotmail.com.
Background:
We aimed to evaluate the microbiological and immunological effects of tissue plasminogen activator (tPA) in a rat model of peritonitis.
Methods:
Twenty-four male Wistar albino rats were divided equally into three groups. Peritonitis and thereafter laparotomy and partial omentectomy were performed in all rats. The control group (C) had no further treatment. The antibiotics group (A) received metronidazole and ceftriaxone. The antibiotic and tPA group (A+T) received the same antibiotics as well as tPA. For microbiological and immunological analysis, blood samples were obtained at the 24th hour, and peritoneal fluid samples were obtained at the 24th and 72nd hours. On the fifth day after surgery, all rats were sacrificed, and the macroscopic findings of the peritoneal cavity were recorded.
Results:
The mean number of intraperitoneal abscesses was significantly higher in the control group and the lowest in the two treatment group (A+T). The levels of cytokines were not significantly different between groups. Giving tPA reduced the number and sizes of the abscesses with no significant difference in inflammatory response.
Conclusion:
In this experimental peritonitis model, it can be postulated that tPA decreased abscess formation without exaggerating the inflammatory response.
